MAM
TBIO

McCarthy Asset Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

McCarthy Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-611
Closed -$4.39K – 40
2023
Q4 		$4.39K Buy
+611
New +$6.79K ﹤0.01% 36

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

McCarthy Asset Management's TBIO Position: Q1 2024 in Review

McCarthy Asset Management sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q1 2024, closing a stake of 611 shares — an estimated $4.39K sold.

McCarthy Asset Management first reported a position in TBIO in Q4 2023 and held it in 1 quarter. The position peaked at $4.39K in Q4 2023. 20 funds tracked by Wall St. Rank hold TBIO as of Q1 2024.

  • McCarthy Asset Management reported no remaining Telesis Bio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • McCarthy Asset Management sold 611 Telesis Bio, Inc. Common Stock shares in Q1 2024, an estimated $4.39K.
  • McCarthy Asset Management first reported a position in Telesis Bio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • McCarthy Asset Management's Telesis Bio, Inc. Common Stock position peaked at $4.39K in Q4 2023.
  • 20 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q1 2024.

Based on McCarthy Asset Management's 13F filing for Q1 2024, filed 9 May 2024.